Inventors:
John L. Lundblad - El Cerrito CA
Miriam D. Budinger - Berkeley CA
Richard S. Schwartz - Burlingame CA
Assignee:
Cutter Laboratories, Inc. - Berkeley CA
International Classification:
A61K 3700, A61K 3514
Abstract:
There is disclosed a pharmaceutical composition for therapeutic use comprising an immune globulin and fibronectin in amounts sufficient to produce an opsonic activity in the composition that is greater than the additive opsonic activity of the individual agents or in amounts sufficient to produce a phagocytosis of infectious agents greater than the additive effect from fibronectin and immune globulin alone.